Dextra is one of our UK based subsidiaries. Founded in 1989 in Reading (UK) Dextra provides a comprehensive service in the synthesis, manufacture and analysis of carbohydrates. With significant expertise in the design of efficient routes, process development, scale up and early stage GMP manufacture of carbohydrate targets, as well as a range of over 1000 complex sugars, Dextra is the most comprehensive source of products and expertise for exploiting the complexity and diversity of glycobiology.

It has gained a world-wide reputation for the supply of rare sugars, monosaccharide building blocks, oligosaccharides, neoglycoproteins, blood group products, functionalised sugars and chiral molecules for medical research, diagnostics, clinical trials as well as other non-pharmaceutical applications.